The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli
Open accessAbstract
Bacteria are simple and cost effective hosts for producing recombinant proteins. However, their physiological features may limit their use for obtaining in native form proteins of some specific structural classes, such as for instance polypeptides that undergo extensive post-translational modifications. To some extent, also the production of proteins that depending on disulfide bridges for their stability has been considered difficult in E. coli.Both eukaryotic and prokaryotic organisms keep their cytoplasm reduced and, consequently, disulfide bond formation is impaired in this subcellular compartment. Disulfide bridges can stabilize protein structure and are often present in high abundance in secreted proteins. In eukaryotic cells such bonds are formed in the oxidizing environment of endoplasmic reticulum during the export process. Bacteria do not possess a similar specialized subcellular compartment, but they have both export systems and enzymatic activities aimed at the formation and at the quality control of disulfide bonds in the oxidizing periplasm.This article reviews the available strategies for exploiting the physiological mechanisms of bactera to produce properly folded disulfide-bonded proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–222 of 222
Lurı́a-Pérez, R., Cedillo‐Barrón, L., Santos‐Argumedo, L., Ortiz-Navarrete, V. F., Ocaña‐Mondragón, A., & González-Bonilla, C. R. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.047 · Cited by 27
de Marco, A. (2008) · Microbial Cell Factories · doi:10.1186/1475-2859-7-20 · Cited by 27
Couprie, J., Vinci, F., Dugave, C., Quéméneur, É., & Moutiez, M. (2000) · Biochemistry · doi:10.1021/bi992873f · Cited by 26
Manipulating the aggregation and oxidation of human SPARC in the cytoplasm of Escherichia coli
Schneider, E. L., Thomas, J. G., Bassuk, J. A., Sage, E. H., & Baneyx, F. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-581 · Cited by 26
Ye, T., Lin, Z., & Lei, H. (2008) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-008-1655-3 · Cited by 25
Effect of modification of connecting peptide of proinsulin on its export
KANG, Y. Y., & Yoon, J. (1994) · Journal of Biotechnology · doi:10.1016/0168-1656(94)90022-1 · Cited by 24
Xu, Y., Lewis, D., & Chou, C.-H. P. (2008) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-008-1514-2 · Cited by 24
Oelschlaeger, P., Lange, S., Schmitt, J. F., Siemann, M., Reuss, M., & Schmid, R. D. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-002-1190-6 · Cited by 23
He, M., Hamon, M., Liu, H., Kang, A. S., & Taussig, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.19.4009 · Cited by 23
Narayanan, N., & Chou, C.-H. P. (2008) · Biotechnology Progress · doi:10.1021/bp0702121 · Cited by 23
Mergulhão, F. J., Monteiro, G. A., Larsson, G., Sandén, A. M., Farewell, A., Nyström, T., Cabral, J. M. S., & Taipa, M. Â. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1232-8 · Cited by 23
Paal, M., Heel, T., Schneider, R., & Auer, B. (2009) · Microbial Cell Factories · doi:10.1186/1475-2859-8-7 · Cited by 23
Miksch, G., Ryu, S., Risse, J. M., & Flaschel, E. (2008) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-008-1673-1 · Cited by 21
Bobovnikova, Y., Graves, P. N., Vlase, H., & Davies, T. F. (1997) · Endocrinology · doi:10.1210/en.138.2.588 · Cited by 21
Effect of SecB Chaperone on Production of Periplasmic Penicillin Acylase in Escherichia coli
Chou, C.-H. P., Tseng, J., Kuo, B.-Y., Lai, K.-N., Lin, M., & Lin, H.-K. (1999) · Biotechnology Progress · doi:10.1021/bp990036z · Cited by 20
Kumano-Kuramochi, M., Xie, Q., Sakakibara, Y., Niimi, S., Sekizawa, K., Komba, S., & Machida, S. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm213 · Cited by 20
Mergulhão, F. J., Monteiro, G. A., Larsson, G., Boström, M., Farewell, A., Nyström, T., Cabral, J. M. S., & Taipa, M. Â. (2003) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20030043 · Cited by 18
Beshay, U., Miksch, G., Friehs, K., & Flaschel, E. (2007) · Biotechnology Letters · doi:10.1007/s10529-007-9477-4 · Cited by 17
Sanders, R. W., Hsu, S. D., van Anken, E., Liscaljet, I. M., Dankers, M. M., Bontjer, I., Land, A., Braakman, I., Bonvin, A. M. J. J., & Berkhout, B. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0670 · Cited by 13
Mukhopadhyay, A. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00482-x · Cited by 12
Kim, S., Cheung, L. H., Zhang, W., & Rosenblum, M. G. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-1133-3 · Cited by 7
Effects of pre-protein overexpression on SecB synthesis in Escherichia coli
Müller, J. P. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb13665.x · Cited by 5
Cited by
Recombinant protein expression in Escherichia coli: advances and challenges
Rosano, G. L., & Ceccarelli, E. A. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00172 · Cited by 2,556
Kaur, J., Kumar, A., & Kaur, J. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.08.080 · Cited by 415
Strategies to Optimize Protein Expression in E. coli
Francis, D. M., & Page, R. (2010) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0524s61 · Cited by 272
Computationally designed libraries for rapid enzyme stabilization
Wijma, H. J., Floor, R. J., Jekel, P. A., Baker, D., Marrink, S. J., & Janssen, D. B. (2014) · Protein Engineering Design and Selection · doi:10.1093/protein/gzt061 · Cited by 269
Post-translational modifications of protein biopharmaceuticals
Walsh, G. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.06.009 · Cited by 263
Metadata
- Authors
- de Marco, A.
- Venue
- Microbial Cell Factories
- Published
- 2009
- Volume
- 8
- Issue
- 1
- Pages
- 26
- ISSN
- 1475-2859 (ISSN-L)
- OpenAlex
- W2166726458
- Cited by
- 367
- References
- 222
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.